Revelation Biosciences, Inc.
REVB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,499 | $11,992 | $5,253 | $1,275 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $67 | $156 | $160 | $637 |
| Total Curr. Assets | $6,566 | $12,148 | $5,413 | $1,912 |
| Property Plant & Equip (Net) | $56 | $65 | $90 | $130 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $56 | $65 | $90 | $130 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6,622 | $12,213 | $5,503 | $2,042 |
| Liabilities | – | – | – | – |
| Payables | $784 | $1,360 | $554 | $596 |
| Short-Term Debt | $0 | $0 | $0 | $17 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,130 | $4,205 | $3,897 | $1,529 |
| Total Curr. Liab. | $1,914 | $5,565 | $4,451 | $2,142 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $17 |
| Total Liabilities | $1,914 | $5,565 | $4,451 | $2,142 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $0 | $0 | $0 |
| Retained Earnings | -$40,506 | -$25,467 | -$25,347 | -$14,517 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $45,213 | $32,115 | $26,399 | $14,418 |
| Total Equity | $4,708 | $6,648 | $1,052 | -$99 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6,622 | $12,213 | $5,503 | $2,042 |
| Net Debt | -$6,499 | -$11,992 | -$5,253 | -$1,258 |